2014 / Placebo-controlled, double-blind, randomized trial
Daily sulforaphane derived from broccoli sprout extracts significantly improved behavioral measures in young men with moderate to severe autism spectrum disorder.
In a randomized trial, 44 young men aged 13-27 with moderate to severe ASD received daily oral sulforaphane (50-150 µmol; n=29) or placebo (n=15) for 18 weeks, followed by 4 weeks without treatment. After 18 weeks, the placebo group experienced minimal change (<3.3%), while the sulforaphane group showed a 34% decline on the ABC (P < 0.001) and a 17% decline on the SRS (P = 0.017), indicating behavioral improvement. On the CGI-I, significantly more participants receiving sulforaphane showed improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007). Scores on all scales returned toward pretreatment levels after treatment discontinuation.
Singh K, Connors SL, Macklin EA, et al. Proc Natl Acad Sci U S A, 2014. PMID 25313065